Press Releases :: Viveve Medical, Inc. (VIVE)

A Global Women’s Intimate Health Company

Viveve Appoints Two New Independent Board Members

Sep 13, 2018

Viveve Submits Investigational Device Exemption to FDA to Conduct LIBERATE-U.S. Trial for Improvement of Stress Urinary Incontinence

Sep 11, 2018

Viveve to Present at 20th Annual Rodman & Renshaw Global Investment Conference

Aug 28, 2018

Viveve Initiates LIBERATE-International Trial for Improvement of Stress Urinary Incontinence

Aug 14, 2018

Viveve Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Aug 9, 2018

Viveve Announces FDA Approval to Continue VIVEVE II Clinical Study

Aug 7, 2018

Viveve to Announce Financial Results for Second Quarter 2018 and Host Conference Call

Aug 2, 2018

Viveve Reports Preliminary Second Quarter 2018 Revenue of $5.5 million

Jul 10, 2018

Viveve Submits VIVEVE II Clinical Study 30-Day Patient Safety Data to FDA

Jul 3, 2018

Viveve Reports Positive Six-Month Data from Stress Urinary Incontinence Feasibility Study

Jun 18, 2018